Drug Shortage Report for MANNITOL INJECTION, USP

Last updated on 2022-10-13 History
Report ID 162159
Drug Identification Number 02243176
Brand name MANNITOL INJECTION, USP
Common or Proper name MANNITOL INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MANNITOL
Strength(s) 25%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50mL
ATC code B05BC
ATC description I.V. SOLUTIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-06-02
Estimated end date 2022-10-12
Actual end date 2022-10-12
Shortage status Resolved
Updated date 2022-10-13
Company comments On 100% allocation until September 30, 2022. We will be encountering a supply interruption on our Mannitol Injection 250 mg/mL SD Vial 50 mL effective October 1, 2022 until October 12, 2022.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-10-13 English Compare
v6 2022-10-02 French Compare
v5 2022-10-02 English Compare
v4 2022-09-01 French Compare
v3 2022-09-01 English Compare
v2 2022-06-08 French Compare
v1 2022-06-08 English Compare

Showing 1 to 7 of 7